TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show October 30, 2009
TCL Archive NCI Plans Network for Providing Access To Pathology Information Over The Web November 12, 1999